SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-06-006724
Filing Date
2006-07-10
Accepted
2006-07-10 08:30:21
Documents
2
Period of Report
2006-07-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS INC. 8-K a5183809.txt 8-K 4288
2 EXHIBIT 99.1 PRESS RELEASE a5183809ex99_1.txt EX-99.1 6176
  Complete submission text file 0001157523-06-006724.txt   12044
Mailing Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111 212-994-8200
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 06952544
SIC: 2836 Biological Products, (No Diagnostic Substances)